Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
72.40    -3.70 (-4.86%)
Bid:
72.00
Ask:
72.80
Spread: 0.80 (1.111%)
Market Cap: £268.72m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

Director/PDMR Shareholding

28 Jan 2025 14:06

RNS Number : 9989U
RWS Holdings PLC
28 January 2025
Β 

28 January 2025

RWS Holdings plc

Notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

RWS Holdings plcΒ ("RWS", the "Company"), a unique world-leading provider of technology-enabled language, content and intellectual property services, announces that options ("Options") over ordinary shares of 1 pence each in the Company ("Ordinary Shares") were granted under the RWS Holdings plc Long Term Incentive Plan ("LTIP") onΒ 24 January 2025Β to PDMRs as outlined below.

The Options were granted with an exercise price per Ordinary Share of nil.

PDMR

Position

No. of Shares under Option

Benjamin Faes

Chief Executive Officer

1,397,357

Candida Davies

Chief Financial Officer

455,729

Jane Hyde

General Counsel and Company Secretary

174,669

Vasagi Kothandapani

President, Enterprise Services

177,979

Mark Lawyer

President,Β Regulated Industries & Linguistic AI

208,829

Christopher Lewey

Group Corporate Development Director

142,192

Amanda Newton

President, Global Content Services

181,021

Maria Schnell

Chief Language Officer

175,672

Jacqui Taylor

Chief People Officer

107,977

Β 

The extent to which the Options will vest will be dependent on RWS's total shareholder return ("TSR") over the period from 2 December 2024, being the date the CEO joined the Company, to the normal vesting date of 24 January 2028. A sliding scale of vesting percentages applies from zero vesting at 10% TSR p.a. to full vesting at 40% TSR p.a. over the performance period.

The performance condition for the Options provides for discretion to be retained by the Committee to reduce the level of vesting that would apply (including to nil vesting) if it considers there has not been an underlying improvement in the financial performance of the Company over the performance period or to counter windfall gains.

The Options have a normal vesting date of the third anniversary of the grant date and will ordinarily be forfeited in the event of cessation of employment ahead of the vesting date.

The Options granted to Benjamin Faes and Candida Davies are subject to a holding period condition under which any shares acquired under the Options (net of sales for tax and national insurance) must be retained until at least the fifth anniversary of the grant date.

Once vested, Options ordinarily will remain exercisable in respect of their vested shares until the tenth anniversary of the award's grant date.

This announcement is made in accordance with Article 19(3) of the EU Market Abuse Regulation 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).

For further information, please contact:

RWS Holdings plc

Julie Southern, Chairman

Benjamin Faes, Chief Executive Officer

Β 

Β 

01753 480200

Β 

MHP (Financial PR advisor)

Katie Hunt / Eleni Menikou

Β 

rws@mhpgroup.com

020 3128 8100

07884 494112

Deutsche Numis (Nomad & Joint Broker)

Stuart Skinner / William Wickham

Β 

Β 

020 7260 1000

Β 

Berenberg (Joint Broker)

Ben Wright / Toby Flaux / Mike Burke / Milo Bonser

Β 

020 3207 7800

Β 

About RWS:

RWS HoldingsΒ plcΒ is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our combination of AI-enabled technology and human expertise helps our clients to grow by ensuring they are understood anywhere, in any language.

Our purpose is unlocking global understanding. By combining cultural understanding, client understanding and technical understanding, our services and technology assist our clients to acquire and retain customers, deliver engaging user experiences, maintain compliance and gain actionable insights into their data and content.

Over the past 20 years we've been evolving our own AI solutions as well as helping clients to explore, build and use multilingual AI applications. With 40+ AI-related patents and more than 100 peer-reviewed papers, we have the experience and expertise to support clients on their AI journey.

We work with over 80% of the world's top 100 brands, more than three-quarters of Fortune's 20 'Most Admired Companies' and almost all of the top pharmaceutical companies, investment banks, law firms and patent filers. Our client base spans Europe, Asia Pacific, Africa and North and South America. Our 65+ global locations across five continents service clients in the automotive, chemical, financial, legal, medical, pharmaceutical, technology and telecommunications sectors.

Founded in 1958, RWS is headquartered in the UK and publicly listed on AIM, theΒ London Stock ExchangeΒ regulated market (RWS.L).Β 

For further information, please visit:Β www.rws.com.

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

Β 

a)

Β 

Name

Β 

Β 

1. Benjamin Faes

2. Candida Davies

3. Jane Hyde

4. Vasagi Kothandapani

5. Mark Lawyer

6. Christopher Lewey

7. Amanda Newton

8. Maria Schnell

9. Jacqui Taylor

Β 

Β 

Β 

2

Β 

Reason for the notification

Β 

Β 

a)

Β 

Position/status

Β 

Β 

1. Chief Executive Officer

2. Chief Financial Officer

3. General Counsel and Company Secretary

4. President, Enterprise Services

5. President, Regulated Industries & Linguistic AI

6. Group Corporate Development Director

7. President, Global Content Services

8. Chief Language Officer

9. Chief People Officer

Β 

Β 

Β 

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial Announcement

Β 

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

Β 

a)

Β 

Name

Β 

Β 

RWS Holdings plc

Β 

b)

Β 

LEI

Β 

Β 

213800YGBGTTSKUVK111

Β 

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Ordinary shares of 1p each

Β 

Β 

Β 

Β 

GB00BVFCZV34

Β 

Identification code

Β 

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Grant of nil cost options under the RWS Holdings plc Long Term Incentive Plan.

Β 

Β 

Β 

c)

Β 

Price(s) and volume(s)

Price(s)

Volume(s)

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

7. Nil

8. Nil

9. Nil

1. 1,397,357

2. 455,729

3. 174,669

4. 177,979

5. 208,829

6. 142,192

7. 181,021

8. 175,672

9. 107,977

Β 

d)

Β 

Aggregated information

- Aggregated volume

3,021,425

- Price

Nil

e)

Β 

Date of the transaction

Β 

Β 

24 January 2025

f)

Β 

Place of the transaction

Β 

Β 

Outside of a trading venue

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHPKFBKQBKDPDB
Date   Source Headline
3rd Oct 20257:00 amRNSDirectorate Change
2nd Oct 202511:38 amRNSHolding(s) in Company
1st Oct 20257:00 amRNSTotal Voting Rights
1st Sep 20253:09 pmRNSTotal Voting Rights
28th Aug 20257:00 amRNSHolding(s) in Company
18th Aug 20257:00 amRNSHolding(s) in Company
8th Aug 202511:11 amRNSHolding(s) in Company
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 20257:00 amRNSDirector/PDMR Shareholding
28th Jul 20259:25 amRNSHolding(s) in Company
23rd Jul 20254:29 pmRNSHolding(s) in Company
18th Jul 20251:19 pmRNSHolding(s) in Company - amendment
16th Jul 20254:01 pmRNSHolding(s) in Company
2nd Jul 20259:00 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSTotal Voting Rights
30th Jun 20257:00 amRNSChange of Nominated Adviser
26th Jun 202511:00 amRNS-RAcquisition of IP of Papercup
23rd Jun 202510:46 amRNSHolding(s) in Company
18th Jun 202512:30 pmRNSHolding(s) in Company
18th Jun 202510:12 amRNSHolding(s) in Company
17th Jun 202511:29 amRNSFurther re Half Year Report
17th Jun 20257:00 amRNSHalf-year Report
11th Jun 20257:00 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSHolding(s) in Company
6th Jun 20257:00 amRNSHolding(s) in Company
2nd Jun 20257:00 amRNSTotal Voting Rights
12th May 20259:15 amRNS-RAppointment of Chief Product & Technology Officer
8th May 202511:51 amRNSDirector/PDMR Shareholding
6th May 202510:10 amRNSHolding(s) in Company
2nd May 20259:15 amRNSHolding(s) in Company
1st May 20252:15 pmRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSTotal Voting Rights
30th Apr 20257:00 amRNSHolding(s) in Company
29th Apr 20257:00 amRNSHolding(s) in Company
28th Apr 20257:00 amRNSHolding(s) in Company
25th Apr 20257:00 amRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSTrading Statement
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20257:00 amRNSChange of Registered Office
3rd Mar 20258:55 amRNSTotal Voting Rights
14th Feb 20253:51 pmRNSHolding(s) in Company
13th Feb 202512:33 pmRNSDirector/PDMR Shareholding
11th Feb 202512:14 pmRNSResult of AGM
11th Feb 20257:00 amRNSAGM Statement
10th Feb 20254:57 pmRNSHolding(s) in Company
3rd Feb 20255:00 pmRNSDirector/PDMR Shareholding
3rd Feb 20254:58 pmRNSDirector/PDMR Shareholding
3rd Feb 20257:00 amRNSTotal Voting Rights
28th Jan 20252:06 pmRNSDirector/PDMR Shareholding
28th Jan 20252:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.